Plain-English translation of NCT06383208 on ClinicalTrials.gov ↗ · Source last updated ·
Researchers want to understand why some people with both coronary heart disease and chronic kidney disease have worse outcomes even when doctors carefully manage their condition. This study will analyze special molecules in your blood called lipid metabolites to find patterns that might predict which patients are at higher risk for serious heart and kidney problems.
People who have both heart disease and kidney disease together face higher risks of dangerous complications, but current treatments don't work well enough for everyone. New research has shown that certain fat-related substances in the blood may be important warning signs, so this study aims to develop a better tool to identify which patients need more aggressive care.
You likely qualify if…
You likely don't qualify if…
You will have blood samples taken to measure the special fat molecules researchers are studying, and your doctors will collect information about your heart disease, kidney disease, and current treatments. The study will follow your health outcomes over time using your medical records. You will not receive any experimental medication — researchers are simply analyzing your blood to develop a better prediction tool for patient risk.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China